Last reviewed · How we verify

Nutriflex Lipid special + Pulmocare

B. Braun Melsungen AG · Phase 3 active Small molecule

Nutriflex Lipid special + Pulmocare is a Small molecule drug developed by B. Braun Melsungen AG. It is currently in Phase 3 development for Nutritional support in patients with pulmonary disease or respiratory compromise requiring parenteral nutrition, Support for mechanically ventilated patients or those at risk of respiratory failure.

Nutriflex Lipid special + Pulmocare is a parenteral nutrition formulation designed to provide comprehensive macronutrient and micronutrient support optimized for patients with pulmonary disease or respiratory compromise.

Nutriflex Lipid special + Pulmocare is a parenteral nutrition formulation designed to provide comprehensive macronutrient and micronutrient support optimized for patients with pulmonary disease or respiratory compromise. Used for Nutritional support in patients with pulmonary disease or respiratory compromise requiring parenteral nutrition, Support for mechanically ventilated patients or those at risk of respiratory failure.

At a glance

Generic nameNutriflex Lipid special + Pulmocare
SponsorB. Braun Melsungen AG
ModalitySmall molecule
Therapeutic areaNutrition Support / Critical Care
PhasePhase 3

Mechanism of action

This is a combination nutritional product that delivers lipids, amino acids, carbohydrates, vitamins, and minerals intravenously. The Pulmocare component is specifically formulated to support respiratory function and reduce respiratory quotient through optimized macronutrient ratios, which may reduce CO2 production and ease ventilatory burden in patients with compromised lung function.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Nutriflex Lipid special + Pulmocare

What is Nutriflex Lipid special + Pulmocare?

Nutriflex Lipid special + Pulmocare is a Small molecule drug developed by B. Braun Melsungen AG, indicated for Nutritional support in patients with pulmonary disease or respiratory compromise requiring parenteral nutrition, Support for mechanically ventilated patients or those at risk of respiratory failure.

How does Nutriflex Lipid special + Pulmocare work?

Nutriflex Lipid special + Pulmocare is a parenteral nutrition formulation designed to provide comprehensive macronutrient and micronutrient support optimized for patients with pulmonary disease or respiratory compromise.

What is Nutriflex Lipid special + Pulmocare used for?

Nutriflex Lipid special + Pulmocare is indicated for Nutritional support in patients with pulmonary disease or respiratory compromise requiring parenteral nutrition, Support for mechanically ventilated patients or those at risk of respiratory failure.

Who makes Nutriflex Lipid special + Pulmocare?

Nutriflex Lipid special + Pulmocare is developed by B. Braun Melsungen AG (see full B. Braun Melsungen AG pipeline at /company/b-braun-melsungen-ag).

What development phase is Nutriflex Lipid special + Pulmocare in?

Nutriflex Lipid special + Pulmocare is in Phase 3.

What are the side effects of Nutriflex Lipid special + Pulmocare?

Common side effects of Nutriflex Lipid special + Pulmocare include Hyperglycemia, Hypertriglyceridemia, Electrolyte imbalances, Catheter-related complications, Hepatic dysfunction.

Related